These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30024540)

  • 1. Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis.
    Zhu B; Zhu Q; Li N; Wu T; Liu S; Liu S
    Medicine (Baltimore); 2018 Jul; 97(29):e11531. PubMed ID: 30024540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis.
    Huang XL; Zhang L; Duan Y; Wang YJ; Wang J
    Arch Med Res; 2016 Apr; 47(3):223-31. PubMed ID: 27255354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis.
    Zhang MY; Dini AA; Yang XK; Li LJ; Wu GC; Leng RX; Pan HF; Ye DQ
    Arch Dermatol Res; 2017 Oct; 309(8):625-635. PubMed ID: 28702765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of High-mobility group box 1 levels and multiple sclerosis: A systematic review and meta-analysis.
    Zhen C; Wang Y; Li D; Zhang W; Zhang H; Yu X; Wang X
    Mult Scler Relat Disord; 2019 Jun; 31():87-92. PubMed ID: 30953953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis.
    Zhu B; Li N; Zhu Q; Wu T; Heizati M; Wang G; Yao X; Luo Q; Liu S; Liu S; Hong J
    Medicine (Baltimore); 2019 Feb; 98(6):e14493. PubMed ID: 30732222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of maternal blood high-mobility group box 1 levels and adverse pregnancy outcomes: A systematic review and meta-analysis.
    Xue L; Chen R; Liu Y; Niu P; Zhou J; Liu J; Zhang J; Chen H
    Reprod Biol; 2024 Jun; 24(2):100859. PubMed ID: 38492434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating blood HMGB1 levels with ischemic stroke: a systematic review and meta-analysis.
    Le K; Mo S; Lu X; Idriss Ali A; Yu D; Guo Y
    Neurol Res; 2018 Nov; 40(11):907-916. PubMed ID: 30015578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum levels of high mobility group box-1 protein and pancreatitis: a meta-analysis.
    Lin Y; Lin LJ; Jin Y; Cao Y; Zhang Y; Zheng CQ; Liu JL; Yang SL
    Biomed Res Int; 2015; 2015():430185. PubMed ID: 25695079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus.
    Tanaka A; Ito T; Kibata K; Inagaki-Katashiba N; Amuro H; Nishizawa T; Son Y; Ozaki Y; Nomura S
    Lupus; 2019 Aug; 28(9):1120-1127. PubMed ID: 31299881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma/Serum Leptin Levels in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-analysis.
    Mei YJ; Wang P; Chen LJ; Li ZJ
    Arch Med Res; 2016 Feb; 47(2):111-7. PubMed ID: 27016486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus.
    Hossny E; El-Ghoneimy D; Soliman DA; Ashour A
    Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients.
    Wang C; Miao Y; Wu X; Huang Y; Sun M; Zhu Y; Zheng F; Sun W; Dong L
    J Immunol Res; 2016; 2016():6537248. PubMed ID: 27800496
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
    Li HM; Zhang TP; Leng RX; Li XP; Li XM; Pan HF
    Arch Med Res; 2015 Oct; 46(7):551-6. PubMed ID: 26452329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin.
    Chen M; Zhu L; Xue M; Zhu R; Jing L; Wang H; Qin Y
    Sci Rep; 2021 Mar; 11(1):5059. PubMed ID: 33658546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
    Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
    Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.
    de Souza AW; van der Geest KS; Brouwer E; Pinheiro FA; Oliveira AC; Sato EI; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Arthritis Res Ther; 2015 Jun; 17(1):158. PubMed ID: 26062541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
    Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis.
    Zhan H; Li H; Liu C; Cheng L; Yan S; Li Y
    Front Immunol; 2021; 12():674343. PubMed ID: 34122433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.